Literature DB >> 32428901

Convalescent COVID-19 Patients on Hemodialysis: When Should We End Isolation?

Ahmet Murt1, Mehmet Rıza Altıparmak2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32428901      PMCID: PMC7270057          DOI: 10.1159/000508380

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


× No keyword cloud information.
Dear Editor, All hemodialysis facilities are putting extensive efforts to protect their patients from the COVID-19 pandemic. Screening for the symptoms is the first step of all. When there is fever, cough, or shortness of breath, the patient becomes a suspected case to be tested for COVID-19. Suspected and confirmed COVID-19 patients should ideally be dialysed in a separate isolation room [1]. When an isolation room cannot be established, these patients may be placed in the last shift or sent to a COVID-19 designated dialysis facility. The staff should follow institutional guidance to use appropriate personal protective equipment. All of the suggested algorithms necessitate isolation of patients when they are either suspected or confirmed COVID-19 cases [2]. Many institutions have established isolation rooms for dialysis, and experiences in this context are growing. As understanding of the disease evolves, we have more patients for whom a discharge is planned, and none of the guides has mentioned about the ideal timing to end the isolation for hemodialysis patients yet. The following are the generally accepted criteria to discharge patients from COVID wards: being afebrile for at least three consecutive days having two negative respiratory SARS-CoV2 PCR tests done 24 hours apart having improved respiratory symptoms with absorbed inflammation in imaging studies. Discharging a patient from a COVID ward may be relatively easy when compared to a nephrologist's dilemma to decide the best for both this particular patient and other hemodialysis patients. Should this patient be accepted to a standard facility as the PCR tests are negative? We know that RT-PCR done for SARS-CoV2 has 70% sensitivity [3] and it can miss some cases even if it is done twice. Although not extensively studied yet, viral shedding could be detected on the 37th day for SARS-CoV2, with a median of 20 days [4]. Besides, PCR assays may turn positive for some discharged patients [5]. In summary, we suggest that nephrologists should continue hemodialysis in an isolation room even if the patient is discharged. The use of relevant personal protective equipment should also be continued during this period. The decision to end the isolation should be given with an additional PCR test which is done 1 month after the patient was confirmed to have COVID-19. We believe that such an approach will be valuable to protect other patients as viral shedding may continue even if the patient is accepted to be convalescent.

Disclosure Statement

The authors have no conflicts of interest to declare.

Funding Sources

The authors did not receive any funding.

Author Contributions

Dr. Ahmet Murt conceptualized the idea, did the literature search, and wrote the manuscript. Prof. Mehmet Riza Altiparmak supervised the work and revised the text.
  5 in total

1.  On the Frontline of the COVID-19 Outbreak: Keeping Patients on Long-Term Dialysis Safe.

Authors:  Suzanne Watnick; Elizabeth McNamara
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-28       Impact factor: 8.237

2.  Mitigating Risk of COVID-19 in Dialysis Facilities.

Authors:  Alan S Kliger; Jeffrey Silberzweig
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-20       Impact factor: 8.237

3.  Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR.

Authors:  Yicheng Fang; Huangqi Zhang; Jicheng Xie; Minjie Lin; Lingjun Ying; Peipei Pang; Wenbin Ji
Journal:  Radiology       Date:  2020-02-19       Impact factor: 11.105

4.  Polymerase Chain Reaction Assays Reverted to Positive in 25 Discharged Patients With COVID-19.

Authors:  Jing Yuan; Shanglong Kou; Yanhua Liang; Jianfeng Zeng; Yanchao Pan; Lei Liu
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

5.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

  5 in total
  1 in total

1.  Age and multimorbidities as poor prognostic factors for COVID-19 in hemodialysis: a Lebanese national study.

Authors:  Mabel Aoun; Rabab Khalil; Walid Mahfoud; Haytham Fatfat; Line Bou Khalil; Rashad Alameddine; Nabil Afiouni; Issam Ibrahim; Mohamad Hassan; Haytham Zarzour; Ali Jebai; Nina Mourad Khalil; Luay Tawil; Zeina Mechref; Zuhair El Imad; Fadia Chamma; Ayman Khalil; Sandy Zeidan; Balsam El Ghoul; Georges Dahdah; Sarah Mouawad; Hiba Azar; Kamal Abou Chahine; Siba Kallab; Bashir Moawad; Ahmad Fawaz; Joseph Homsi; Carmen Tabaja; Maya Delbani; Rami Kallab; Hassan Hoballah; Wahib Haykal; Najat Fares; Walid Rahal; Wael Mroueh; Mohammed Youssef; Jamale Rizkallah; Ziad Sebaaly; Antoine Dfouni; Norma Ghosn; Nagi Nawfal; Walid Abou Jaoude; Nadine Bassil; Therese Maroun; Nabil Bassil; Chadia Beaini; Boutros Haddad; Elie Moubarak; Houssam Rabah; Amer Attieh; Serge Finianos; Dania Chelala
Journal:  BMC Nephrol       Date:  2021-02-27       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.